{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:11:40Z","timestamp":1790820700689,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecules and Cells"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1007\/s10059-010-0083-2","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T05:46:33Z","timestamp":1279604793000},"page":"13-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Characterization of a Novel Mucopolysaccharidosis Type II Mouse Model and Recombinant AAV2\/8 Vector-Mediated Gene Therapy"],"prefix":"10.1016","volume":"30","author":[{"given":"Sung-Chul","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Sook","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Nam","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Hwa","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Kyu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s10059-010-0083-2_bib1","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1172\/JCI114010","article-title":"Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiency","volume":"83","author":"Birkenmeier","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1007\/s10059-010-0083-2_bib2","doi-asserted-by":"crossref","first-page":"11830","DOI":"10.1073\/pnas.90.24.11830","article-title":"Metabolic correction and crosscorrection of mucopolysaccharidosis type II (Hunter syndrome) by retroviral-mediated gene transfer and expression of human iduronate-2-sulfatase","volume":"90","author":"Braun","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1007\/s10059-010-0083-2_bib3","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.molmed.2003.08.004","article-title":"Significance of immune response to enzyme-replacement therapy for patients with a lysosomal storage disorder","volume":"9","author":"Brooks","year":"2003","journal-title":"Trends Mol. Med."},{"key":"10.1007\/s10059-010-0083-2_bib4","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/hmg\/ddl038","article-title":"Correction of Hunter syndrome in the MPS II mouse model by AAV2\/8-mediated gene delivery","volume":"15","author":"Cardone","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1007\/s10059-010-0083-2_bib5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/6.4.503","article-title":"Murine mucopolysaccharidosis type I: targeted disruption of the murine alpha-L-iduronidase gene","volume":"6","author":"Clarke","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1007\/s10059-010-0083-2_bib6","first-page":"227","article-title":"Bone marrow transplantation in Hunter syndrome (mucopolysaccharidosis type II): two-year follow-up of the first Italian patient and review of the literature","volume":"17","author":"Coppa","year":"1995","journal-title":"Pediatr. Med. Chir."},{"key":"10.1007\/s10059-010-0083-2_bib7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0925-4439(02)00166-7","article-title":"Uptake of recombinant iduronate-2-sulfatase into neuronal and glial cells in vitro","volume":"1588","author":"Daniele","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1007\/s10059-010-0083-2_bib8","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1128\/CMR.00008-08","article-title":"Gene therapy using adeno-associated virus vectors","volume":"21","author":"Daya","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1007\/s10059-010-0083-2_bib9","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/sj.gt.3300411","article-title":"In vitro correction of iduronate-2-sulfatase deficiency by adenovirus-mediated gene transfer","volume":"4","author":"Di Francesco","year":"1997","journal-title":"Gene Ther."},{"key":"10.1007\/s10059-010-0083-2_bib10","doi-asserted-by":"crossref","first-page":"8214","DOI":"10.1073\/pnas.93.16.8214","article-title":"Targeted disruption of the arylsulfatase B gene results in mice resembling the phenotype of mucopolysaccharidosis VI","volume":"93","author":"Evers","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1007\/s10059-010-0083-2_bib11","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s10545-007-0641-8","article-title":"The characterization of a murine model of mucopolysaccharidosis II (Hunter syndrome)","volume":"30","author":"Garcia","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1007\/s10059-010-0083-2_bib12","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1128\/JVI.80.1.426-439.2006","article-title":"Liver transduction with recombinant adeno-associated virus is primarily restricted by capsid serotype not vector genotype","volume":"80","author":"Grimm","year":"2006","journal-title":"J. Virol."},{"key":"10.1007\/s10059-010-0083-2_bib13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJM200301163480314","article-title":"A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency","volume":"348","author":"Hacein-Bey-Abina","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1007\/s10059-010-0083-2_bib14","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1073\/pnas.051634498","article-title":"Adeno-associated viral vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple organs of Fabry mice","volume":"98","author":"Jung","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1007\/s10059-010-0083-2_bib15","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1016-8478(23)13736-8","article-title":"Angiogenesis and white blood cell proliferation induced in mice by injection of a prolactin-expressing plasmid into muscle","volume":"15","author":"Ko","year":"2003","journal-title":"Mol. Cells"},{"key":"10.1007\/s10059-010-0083-2_bib16","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/(SICI)1096-8628(19960906)64:4<531::AID-AJMG1>3.0.CO;2-S","article-title":"Biochemical and molecular analysis in a patient with the severe form of Hunter syndrome after bone marrow transplantation","volume":"64","author":"Li","year":"1996","journal-title":"Am. J. Med. Genet."},{"key":"10.1007\/s10059-010-0083-2_bib17","doi-asserted-by":"crossref","first-page":"14505","DOI":"10.1073\/pnas.96.25.14505","article-title":"Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase","volume":"96","author":"Li","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1007\/s10059-010-0083-2_bib18","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/sj.gt.3302036","article-title":"Molecular basis of the inflammatory response to adenovirus vectors","volume":"10","author":"Liu","year":"2003","journal-title":"Gene Ther."},{"key":"10.1007\/s10059-010-0083-2_bib19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.pediatrneurol.2003.09.003","article-title":"The status of hematopoietic stem cell transplantation in lysosomal storage disease","volume":"29","author":"Malatack","year":"2003","journal-title":"Pediatr. Neurol."},{"key":"10.1007\/s10059-010-0083-2_bib20","doi-asserted-by":"crossref","first-page":"e377","DOI":"10.1542\/peds.2007-1350","article-title":"Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome)","volume":"121","author":"Martin","year":"2008","journal-title":"Pediatrics"},{"key":"10.1007\/s10059-010-0083-2_bib21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1651-2227.2002.tb03118.x","article-title":"Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report","volume":"91","author":"Muenzer","year":"2002","journal-title":"Acta Paediatr."},{"key":"10.1007\/s10059-010-0083-2_bib22","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1089\/hum.2004.15.1157","article-title":"The innate immune response to adenovirus vectors","volume":"15","author":"Muruve","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1007\/s10059-010-0083-2_bib23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.bi.60.070191.001353","article-title":"Lysosomal storage diseases","volume":"60","author":"Neufeld","year":"1991","journal-title":"Annu. Rev. Biochem."},{"key":"10.1007\/s10059-010-0083-2_bib24","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1203\/01.PDR.0000132837.29067.0E","article-title":"Longterm enzymatic and phenotypic correction in the phenylketonuria mouse model by adeno-associated virus vector-mediated gene transfer","volume":"56","author":"Oh","year":"2004","journal-title":"Pediatr. Res."},{"key":"10.1007\/s10059-010-0083-2_bib25","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1073\/pnas.94.6.2540","article-title":"alpha-Galactosidase A deficient mice: a model of Fabry disease","volume":"94","author":"Ohshima","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1007\/s10059-010-0083-2_bib26","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/sj.bmt.1702398","article-title":"Hematopoietic cell transplantation for mucopolysaccharidosis IIB (Hunter syndrome)","volume":"25","author":"Peters","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1007\/s10059-010-0083-2_bib27","doi-asserted-by":"crossref","first-page":"15172","DOI":"10.1073\/pnas.0607053103","article-title":"Enzyme therapy in man-nose receptor-null mucopolysaccharidosis VII mice defines roles for the mannose 6-phosphate and mannose receptors","volume":"103","author":"Sly","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1007\/s10059-010-0083-2_bib28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2174\/1566523043346011","article-title":"Why do we need new gene therapy viral vectors? Characteristics, limitations and future perspectives of viral vector transduction","volume":"4","author":"Tomanin","year":"2004","journal-title":"Curr. Gene Ther."},{"key":"10.1007\/s10059-010-0083-2_bib29","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1093\/hmg\/ddg366","article-title":"Mouse model of N-acetylgalactosamine-6-sulfate sulfatase deficiency (Galns-\/-) produced by targeted disruption of the gene defective in Morquio A disease","volume":"12","author":"Tomatsu","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1007\/s10059-010-0083-2_bib30","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1023\/A:1005525931994","article-title":"Long-term follow-up following bone marrow transplantation for Hunter disease","volume":"22","author":"Vellodi","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1007\/s10059-010-0083-2_bib31","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1023\/A:1012763026526","article-title":"A fluorimetric enzyme assay for the diagnosis of MPS II (Hunter disease)","volume":"24","author":"Voznyi","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1007\/s10059-010-0083-2_bib32","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1089\/hum.1996.7.4-537","article-title":"Retroviral-mediated transfer of the iduronate-2-sulfatase gene into lymphocytes for treatment of mild Hunter syndrome (mucopolysaccharidosis type II)","volume":"7","author":"Whitley","year":"1996","journal-title":"Hum. Gene Ther."}],"container-title":["Molecules and Cells"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10059-010-0083-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10059-010-0083-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S101684782310999X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S101684782310999X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10059-010-0083-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T17:43:19Z","timestamp":1760895799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S101684782310999X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S101684782310999X"],"URL":"https:\/\/doi.org\/10.1007\/s10059-010-0083-2","relation":{},"ISSN":["1016-8478"],"issn-type":[{"value":"1016-8478","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of a Novel Mucopolysaccharidosis Type II Mouse Model and Recombinant AAV2\/8 Vector-Mediated Gene Therapy","name":"articletitle","label":"Article Title"},{"value":"Molecules and Cells","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s10059-010-0083-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 THE AUTHORS. Published by Elsevier Inc on behalf of the Korean Society for Molecular and Cellular Biology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}